March 11,
2019
Ultragenyx to Present at Upcoming Investor Conferences
February 26,
2019
Ultragenyx Announces Pricing of Public Offering of Common Stock
Transforming good science
into great medicine
for rare genetic diseases.
Deep and diversified product pipeline
Developing multiple clinical-stage programs in parallel
Focused on serious rare and ultra-rare diseases
Working with patients and medical professionals to treat rare diseases
Dedicated to creating new treatments
Join a high-performance team focused on rare diseases